$1.36-0.03 (-2.16%)
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia.
VolitionRx Limited in the Healthcare sector is trading at $1.36. Wall Street consensus targets $20.21 (4 analysts), implying a +1385.8% move over the next 12 months. The stock is currently near its 52-week low of $1.30, remaining 78.3% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening...
With an upside potential of 1451.32%, VolitionRx Limited (NYSEAMERICAN:VNRX) is among the 7 Best Rated Penny Stocks to Buy According to Wall Street Analysts. On May 15, Cameron Reynolds, President and Group Chief Executive Officer of VolitionRx Limited (NYSEAMERICAN:VNRX), stated that the company made substantial progress across multiple product platforms during the first quarter and following quarter-end […]
VolitionRX Ltd (VNRX) reports a 300% revenue increase and expands its global network, despite rising expenses and ongoing commercialization challenges.
VolitionRX Ltd (VNRX) reports a 133% year-on-year revenue growth and significant partnerships, despite ongoing financial challenges and unpredictable revenue streams.
Moby summary of VolitionRx Limited's Q4 2025 earnings call
VolitionRx (VNRX) announces the completion of all validation and verification of the chemiluminescent immunoassay version of its Nu.Q Vet Cancer Test with Fujifilm Vet Systems Co. in Japan, allowing use of full automation rather than manual plates in central laboratories. Volition’s supply agreement enables Fujifilm Vet Systems to sell and perform the Nu.Q Vet Cancer Test throughout its network of central reference laboratories in Japan. Claim 70% Off TipRanks PremiumUnlock hedge fund-level data